What happens at 5 years of follow-up with thyroidectomy without radioiodine in patients with low-risk thyroid cancer?

In patients with low-risk differentiated thyroid cancer, a follow-up strategy without radioiodine was non-inferior to postoperative radioiodine at 5 years.

Randomized trial · Lancet Diabetes Endocrinol 2025

Reference: Leboulleux. Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial. The Lancet Diabetes & Endocrinology. 2025;13(1):38–46. doi:10.1016/S2213-8587(24)00276-6. PMID:39586309.

Chapters

0:00 Intro

0:38 The trial

3:19 My take

3:50 Outro

Read the structured trial summary at https://hormoneinsight.com

AI narration is used. This podcast is intended for healthcare professionals only. It is educational, not medical advice. Views expressed are the presenter’s own and do not necessarily reflect those of any institution he works with.

Hormone Insight: https://hormoneinsight.com

Apple App Store: https://apps.apple.com/sa/app/hormone-insight/id6749515856

Google Play: https://play.google.com/store/apps/details?id=com.fahadwali78.hormoneinsightmobile&hl=en